Who should I contact about this recall?

Contact Abbott Point Of Care Inc. directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.

Has Abbott Point Of Care Inc. had other FDA recalls or enforcement actions?

Yes. Argus HQ has recorded 7 total FDA actions tied to Abbott Point Of Care Inc., including 7 recalls and 0 warning letters.

What is the current status of this recall?

Status as recorded by FDA: Ongoing.

FDA Class II Recall: i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers:… by Abbott Point Of Care Inc.

Key facts

Recalling firm	Abbott Point Of Care Inc.
Manufacturer	Not disclosed in the FDA record.
Brand name	Not disclosed in the FDA record.
Product description	i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers: K894914, K940918, K223710, K230275, K230285, K230300
Classification	Class II
Recall number	Z-2583-2025
Report date	Not disclosed in the FDA record.
Status	Ongoing
Reason for recall	Lack of a 510(k) premarket clearance for the i-STAT CG8+, EG7+ and EG6+ cartridges to reflect updated sample type for potassium and ionized calcium and measurement ranges for pH and PO2.

Key takeaway: FDA classified a recall by Abbott Point Of Care Inc. as Class II, reported 20250924. The affected product is i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers: K894914, K940918, K223710, K230275, K230285, K230300 (recall number Z-2583-2025). Reason for recall: Lack of a 510(k) premarket clearance for the i-STAT CG8+, EG7+ and EG6+ cartridges to reflect updated sample type for potassium and ionized calcium and measurement ranges for pH and PO2.. Status: Ongoing. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall.

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers: K894914, K940918, K223710, K230275, K230285, K230300 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Abbott Point Of Care Inc.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Abbott Point Of Care Inc. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Abbott Point Of Care Inc. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

What this classification means

A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

Abbott Point Of Care Inc.’s FDA history

Argus HQ has recorded 7 total FDA actions tied to Abbott Point Of Care Inc.: 0 warning letters, 7 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Who should I contact about this recall?: Contact Abbott Point Of Care Inc. directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.
Has Abbott Point Of Care Inc. had other FDA recalls or enforcement actions?: Yes. Argus HQ has recorded 7 total FDA actions tied to Abbott Point Of Care Inc., including 7 recalls and 0 warning letters.
What is the FDA recall number for this event?: FDA recall number Z-2583-2025.
What is the current status of this recall?: Status as recorded by FDA: Ongoing.

Know if this happens again — we'll email you.

Free. No spam, just recall alerts for what you tell us to watch.

Full FDA history for Abbott Point Of Care Inc.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2025). FDA Class II Recall: i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers:… by Abbott Point Of Care Inc. — Recall Details. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/recall/abbott-point-of-care-z-2583-2025-2025-09-24

MLA

"FDA Class II Recall: i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers:… by Abbott Point Of Care Inc. — Recall Details." Argus HQ Research, Digital Empire Holdings LLC, 2025, argushq.ai/recall/abbott-point-of-care-z-2583-2025-2025-09-24.

Chicago

Argus HQ Research. "FDA Class II Recall: i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers:… by Abbott Point Of Care Inc. — Recall Details." Digital Empire Holdings LLC. Accessed August 27, 2026. https://argushq.ai/recall/abbott-point-of-care-z-2583-2025-2025-09-24.

BibTeX

@misc{argushq_argushq_ai_recall_abbott_point_of_care_z_2583_2025_2025_09_24_2025,
  title = {FDA Class II Recall: i-STAT CG8+ cartridge. List Number: 03P88-25. 510(k) numbers:… by Abbott Point Of Care Inc. — Recall Details},
  author = {{Argus HQ Research}},
  year = {2025},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/recall/abbott-point-of-care-z-2583-2025-2025-09-24},
  note = {Accessed: August 27, 2026}
}

Source: FDA.gov — Recalls ↗